Loading cover... Drag cover to reposition
MCV 5-dose implementation

MCV 5-dose implementation

Files
Timeline
About
Albums
Discussions
Events
Members
Announcements
Videos
Audio

Group Resources

Gavi Budget Eligibility Guide

Sassenach 2nd June 2023 121

Gavi Vaccine Funding Guidelines

Sassenach 2nd June 2023 119

Gavi Budgeting Reporting Template

Sassenach 2nd June 2023 123

Gavi Measles Containing Vaccine Presentation Switch Request Form

Sassenach 2nd June 2023 117

La transition du MCV en 10 doses à 5 doses en Inde

Sassenach 21st April 2023 115

5 doses ressource d’une page

Sassenach 21st April 2023 111

5 doses en l'Asie et le Pacifique

Sassenach 21st April 2023 109

5 doses en Afrique_ 2023

Sassenach 21st April 2023 123

Outil d'aide à l'évaluation pour le passage au flacon de 5 doses de VAR

Sassenach 21st April 2023 110

MCV 5-dose Vial Assessment Support Tool

Sassenach 4th April 2023 144

[DUPLICATE] MCV 5-dose Vial Assessment Support Tool

Sassenach 4th April 2023 103

WHO SEARO meeting report (August 2022)

Sassenach 5th December 2022 93

WHO AFRO RITAG meeting report (July 2020)

Sassenach 5th December 2022 91

MCV 5-dose in Asia Pacific (Nov. 2022)

Sassenach 5th December 2022 91

MCV 5-dose in Africa Map (Nov. 2022)

Sassenach 5th December 2022 101

WHO/UNICEF Fact Sheet on Measles and Rubella 5-dose (Updated Sept. 2022)

Sassenach 5th December 2022 122

UNICEF-WHO MCV 5-dose Fact Sheet (Updated Aug. 2022)

Sassenach 5th December 2022 89

Vaccine Hesitancy among Parents and Its Association with the Uptake of Measles Vaccine in Urban Settings in Khartoum State, Sudan (Bosma et al., 2022)

Sassenach 28th July 2022 125

Ethiopia Total Systems Effectiveness Analysis (TSE). Linksbridge/Sassenach, 2022.

Sassenach 12th July 2022 124

Dose Per Container Partnership Immunization decision support resource. DPCP, 2019.

Sassenach 12th July 2022 115

Filters